135 related articles for article (PubMed ID: 33240412)
1. Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53.
Liu R; Li H; Xu Y; Li X; Guo X; Shi J; Cui Y; Wang Z; Liu J
Oncol Lett; 2021 Jan; 21(1):6. PubMed ID: 33240412
[TBL] [Abstract][Full Text] [Related]
2. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.
Zhou Z; Ji Z; Wang Y; Li J; Cao H; Zhu HH; Gao WQ
Gastroenterology; 2014 Nov; 147(5):1043-54. PubMed ID: 25046164
[TBL] [Abstract][Full Text] [Related]
3. TRIM59-mediated ferroptosis enhances neuroblastoma development and chemosensitivity through p53 ubiquitination and degradation.
Liu Y; Jiang N; Chen W; Zhang W; Shen X; Jia B; Chen G
Heliyon; 2024 Feb; 10(4):e26014. PubMed ID: 38434050
[TBL] [Abstract][Full Text] [Related]
4. TRIM59 knockdown blocks cisplatin resistance in A549/DDP cells through regulating PTEN/AKT/HK2.
He R; Liu H
Gene; 2020 Jul; 747():144553. PubMed ID: 32165307
[TBL] [Abstract][Full Text] [Related]
5. TRIM59 as a novel molecular biomarker to predict the prognosis of patients with NSCLC.
Lou M; Gao Z; Zhu T; Mao X; Wang Y; Yuan K; Tong J
Oncol Lett; 2020 Feb; 19(2):1400-1408. PubMed ID: 31966070
[TBL] [Abstract][Full Text] [Related]
6. TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression.
Wang Y; Zhou Z; Wang X; Zhang X; Chen Y; Bai J; Di W
Int J Biol Sci; 2018; 14(14):2073-2082. PubMed ID: 30585270
[TBL] [Abstract][Full Text] [Related]
7. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10.
Tan P; Ye Y; He L; Xie J; Jing J; Ma G; Pan H; Han L; Han W; Zhou Y
PLoS Biol; 2018 Nov; 16(11):e3000051. PubMed ID: 30408026
[TBL] [Abstract][Full Text] [Related]
8. TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway.
Liu Y; Dong Y; Zhao L; Su L; Diao K; Mi X
Mol Carcinog; 2018 Dec; 57(12):1792-1802. PubMed ID: 30175868
[TBL] [Abstract][Full Text] [Related]
9. TRIM59 is a novel potential prognostic biomarker in patients with non-small cell lung cancer: A research based on bioinformatics analysis.
Hao L; Du B; Xi X
Oncol Lett; 2017 Aug; 14(2):2153-2164. PubMed ID: 28789440
[TBL] [Abstract][Full Text] [Related]
10. [Expression of TRIM59 in Non-small Cell Lung Cancer and Its Correlation with Prognosis].
Tian H; Zhang D; Xu R; Qin Y; Lan Y; Jiao W; Han Y
Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):21-28. PubMed ID: 31948534
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
12. SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53.
Che B; Du Y; Yuan R; Xiao H; Zhang W; Shao J; Lu H; Yu Y; Xiang M; Hao L; Zhang S; Du X; Liu X; Zhou W; Wang K; Chen L
Oncogene; 2023 Oct; 42(44):3260-3273. PubMed ID: 37740007
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tripartite motif 59 and its diagnostic utility in benign bowel diseases and colorectal cancer.
Dahpy MA; Salama RHM; Kamal AA; El-Deek HE; AbdelMotaleb AA; Abd-El-Rehim AS; Hassan EA; Alsanory AA; Saad MM; Ali M
J Biochem Mol Toxicol; 2022 Jul; 36(7):e23065. PubMed ID: 35377964
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of tripartite motif-59 inhibits the malignant processes in human colorectal cancer cells.
Wu W; Chen J; Wu J; Lin J; Yang S; Yu H
Oncol Rep; 2017 Oct; 38(4):2480-2488. PubMed ID: 28849218
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of tripartite motif 59 (TRIM59) inhibits tumor growth in prostate cancer.
Lin WY; Wang H; Song X; Zhang SX; Zhou PS; Sun JM; Li JS
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4864-4873. PubMed ID: 27981550
[TBL] [Abstract][Full Text] [Related]
16. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
Zhan W; Han T; Zhang C; Xie C; Gan M; Deng K; Fu M; Wang JB
PLoS One; 2015; 10(11):e0142596. PubMed ID: 26599082
[TBL] [Abstract][Full Text] [Related]
17. TRIM59 is a key regulator of growth and migration inrenal cell carcinoma.
Hu SH; Zhao MJ; Wang WX; Xu CW; Wang GD
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):68-74. PubMed ID: 28719348
[TBL] [Abstract][Full Text] [Related]
18. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
[TBL] [Abstract][Full Text] [Related]
19. TRIM59 promotes cell proliferation, migration and invasion in human hepatocellular carcinoma cells.
Sun G; Sui X; Han D; Gao J; Liu Y; Zhou L
Pharmazie; 2017 Nov; 72(11):674-679. PubMed ID: 29442042
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of MAML1 inhibits proliferation and induces apoptosis of T-cell acute lymphoblastic leukemia cells through SP1-dependent inactivation of TRIM59.
Cheng H; Chen L; Hu X; Qiu H; Xu X; Gao L; Tang G; Zhang W; Wang J; Yang J; Huang C
J Cell Physiol; 2019 Apr; 234(4):5186-5195. PubMed ID: 30370525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
